Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.04 - $2.14 $32,243 - $66,346
-31,003 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.08 - $12.2 $3,619 - $21,228
-1,740 Reduced 5.31%
31,003 $67,000
Q4 2021

Feb 15, 2022

BUY
$11.48 - $17.69 $7,083 - $10,914
617 Added 1.92%
32,743 $389,000
Q3 2021

Nov 15, 2021

BUY
$14.57 - $17.72 $90,858 - $110,501
6,236 Added 24.09%
32,126 $498,000
Q2 2021

Aug 16, 2021

BUY
$20.3 - $33.6 $199,772 - $330,657
9,841 Added 61.32%
25,890 $528,000
Q1 2021

May 18, 2021

BUY
$19.1 - $34.94 $14,878 - $27,218
779 Added 5.1%
16,049 $365,000
Q4 2020

Feb 16, 2021

BUY
$13.2 - $32.74 $201,564 - $499,939
15,270 New
15,270 $422,000

Others Institutions Holding ALGS

# of Institutions
1
Shares Held
227K
Call Options Held
0
Put Options Held
0

About Aligos Therapeutics, Inc.


  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $1.3B
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.